Korean Firms Hunt For Overseas Biologics Manufacturers To Support Growth
US, EU Cell And Gene Therapy Producers In Sights
Korean companies, including large conglomerates and non-biopharmas, are increasingly jumping into biologics manufacturing through cross-border acquisitions following the successes of Samsung and SK.
